ConductScience.org, home

Paper34944934

Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer.

Mayayo-Peralta I and 13 others. Cancers (Basel), 2021. Cited by 8 papers, by iCite.

Cite this record

ConductScience Library. Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer. Papers, record 34944934. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34944934

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Ribociclib Induces Broad Chemotherapy Resistance and EGFR Dependency in ESR1 Wildtype and Mutant Breast Cancer.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2021
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
8
iCite
Relative citation ratio, by iCite
0.39
iCite
Revised in PubMed
2025-05-30
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Mayayo-Peralta IIsabel
2Faggion BBeatrice
3Hoekman LLiesbethhttps://orcid.org/0000-0002-3552-6390
4Morris BBen
5Lieftink CCor
6Goldsbrough IIsabella
7Buluwela LLakjaya
8Siefert JCJoseph C
9Post HHarm
10Altelaar MMaarten
11Beijersbergen RRoderick
12Ali SSimakhttps://orcid.org/0000-0002-1320-0816
13Zwart WWilbert
14Prekovic SStefan

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
12011Cancer Research UKUnited KingdomPubMed
91716401Dutch Research CouncilNetherlandsPubMed
ZwartOncode InstitutePubMed

Source PubMed

Download CSV of grants

References64

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131823286Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells.Breast Cancer2020https://conductscience.org/library/papers/31823286PubMed
216929185Opposing roles of mitogenic and stress signaling pathways in the induction of cancer dormancy.Cell Cycle2006https://conductscience.org/library/papers/16929185PubMed
329662238Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance.Nat Rev Cancer2018https://conductscience.org/library/papers/29662238PubMed
427020857Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor-Positive Breast Cancer.Cancer Res2016https://conductscience.org/library/papers/27020857PubMed
524942700Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ.Mol Cell Proteomics2014https://conductscience.org/library/papers/24942700PubMed
630053671Palbociclib plus endocrine therapy in older women with HR+/HER2- advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies.Eur J Cancer2018https://conductscience.org/library/papers/30053671PubMed
732482536Senescent Cells in Cancer Therapy: Friends or Foes?Trends Cancer2020https://conductscience.org/library/papers/32482536PubMed
829935900Mechanisms of therapeutic CDK4/6 inhibition in breast cancer.Semin Oncol2017https://conductscience.org/library/papers/29935900PubMed
928344165Mechanisms governing metastatic dormancy in breast cancer.Semin Cancer Biol2017https://conductscience.org/library/papers/28344165PubMed
1030205045The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.Cancer Cell2018https://conductscience.org/library/papers/30205045PubMed
1128059068CDK4/6 or MAPK blockade enhances efficacy of EGFR inhibition in oesophageal squamous cell carcinoma.Nat Commun2017https://conductscience.org/library/papers/28059068PubMed
1210787412Aspartate 351 of estrogen receptor alpha is not crucial for the antagonist activity of antiestrogens.J Biol Chem2000https://conductscience.org/library/papers/10787412PubMed
1312736255Mutation of Leu-536 in human estrogen receptor-alpha alters the coupling between ligand binding, transcription activation, and receptor conformation.J Biol Chem2003https://conductscience.org/library/papers/12736255PubMed
1432300189The force awakens: metastatic dormant cancer cells.Exp Mol Med2020https://conductscience.org/library/papers/32300189PubMed
1532541838Senescence as a therapeutically relevant response to CDK4/6 inhibitors.Oncogene2020https://conductscience.org/library/papers/32541838PubMed
162063198A corticosteroid receptor in neuronal membranes.Science1991https://conductscience.org/library/papers/2063198PubMed
1720371346A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations.Cell2010https://conductscience.org/library/papers/20371346PubMed
1831318440ESR1 mutations in breast cancer.Cancer2019https://conductscience.org/library/papers/31318440PubMed
1928027327Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis.PLoS Med2016https://conductscience.org/library/papers/28027327PubMed
2029555874Reactivation of Mutant-EGFR Degradation through Clathrin Inhibition Overcomes Resistance to EGFR Tyrosine Kinase Inhibitors.Cancer Res2018https://conductscience.org/library/papers/29555874PubMed

See all 64 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.

PMIDTitleJournalYearIn PapersSource
41677624Identification of Resistance Genes in Breast Cancer Cells Treated with Fulvestrant and Ribociclib via Retroviral Screening and Integration Site Sequencing.Cells2026https://conductscience.org/library/papers/41677624PubMed
41444499LEM4 interacts with β-catenin and promotes β-catenin-dependent transcription activity to confers ribociclib resistance in breast cancer cells.Sci Rep2025https://conductscience.org/library/papers/41444499PubMed
39917165Interactions between key genes and pathways in prostate cancer progression and therapy resistance.Front Oncol2025https://conductscience.org/library/papers/39917165PubMed
38084101Genome-wide CRISPR/Cas9 screening for drug resistance in tumors.Front Pharmacol2023https://conductscience.org/library/papers/38084101PubMed
37035239CDK4/6 inhibitor resistance in estrogen receptor positive breast cancer, a 2023 perspective.Front Cell Dev Biol2023https://conductscience.org/library/papers/37035239PubMed
35800743Identification of immune-related biomarkers for predicting neoadjuvant chemotherapy sensitivity in HER2 negative breast cancer via bioinformatics analysis.Gland Surg2022https://conductscience.org/library/papers/35800743PubMed

Download CSV of cited by

Genes24

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AKT2208PubTator's text mininghttps://conductscience.org/library/genes/208NCBI Gene
AKT310000PubTator's text mininghttps://conductscience.org/library/genes/10000NCBI Gene
AURKA6790PubTator's text mininghttps://conductscience.org/library/genes/6790NCBI Gene
CDCA783879PubTator's text mininghttps://conductscience.org/library/genes/83879NCBI Gene
CDK1983PubTator's text mininghttps://conductscience.org/library/genes/983NCBI Gene
CDK21017PubTator's text mininghttps://conductscience.org/library/genes/1017NCBI Gene
CDK41019PubTator's text mininghttps://conductscience.org/library/genes/1019NCBI Gene
CDK61021PubTator's text mininghttps://conductscience.org/library/genes/1021NCBI Gene
COL11A21302PubTator's text mininghttps://conductscience.org/library/genes/1302NCBI Gene
EGFR1956PubTator's text mininghttps://conductscience.org/library/genes/1956NCBI Gene
EREG2069PubTator's text mininghttps://conductscience.org/library/genes/2069NCBI Gene
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
GLB12720PubTator's text mininghttps://conductscience.org/library/genes/2720NCBI Gene
GPR166P442206PubTator's text mininghttps://conductscience.org/library/genes/442206NCBI Gene
HSP90AA13320PubTator's text mininghttps://conductscience.org/library/genes/3320NCBI Gene
MAPK15594PubTator's text mininghttps://conductscience.org/library/genes/5594NCBI Gene
MAPK85599PubTator's text mininghttps://conductscience.org/library/genes/5599NCBI Gene
MTOR2475PubTator's text mininghttps://conductscience.org/library/genes/2475NCBI Gene
NR3C12908PubTator's text mininghttps://conductscience.org/library/genes/2908NCBI Gene

See all 24 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/34944934

GET https://conductscience.org/api/papers/v1/34944934/references?page=2